H.R. 8339 · 119th Congress · House

Drug Origin Transparency Act of 2026

Active· Referred to the House Committee on Energy and Commerce.
Introduced
Apr 16, 26
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Committees

1

Energy and Commerce Committee

hsif00

Referred: Apr 16, 2026

Active